Ricerca di contatti, progetti,
corsi e pubblicazioni

MuTaLig - Multi-target paradigm for innovative ligand identification in the drug discovery process

Persone

 

Limongelli V.

(Responsabile)

Abstract

The aim of this COST Action is to join highly-qualified research teams working in disciplines around the field of medicinal chemistry, into a novel network devoted to the multi-target issue in drug discovery. The choice of this theme is related to its marked multidisciplinary character, which can ensure a strong interaction among all COST Action participants. Currently, an important and emerging issue in modern drug discovery is to design novel or identify existing bioactive compounds, endowed with the capability to interact selectively with two or more macromolecular targets, exerting their effects against certain therapeutic goals in a synergic fashion. This leading concept stimulated this COST Action focusing on novel ligands able to recognize selected multiple targets, to promote closer scientific links among European research groups involved in medicinal chemistry field at both academic and industrial level. The research competencies of the network will span around medicinal chemistry, from synthetic chemistry, natural products and biophysics to theoretical chemistry, molecular modelling and biological screening.

Informazioni aggiuntive

Acronimo
MuTaLig
Data d'inizio
16.03.2016
Data di fine
17.10.2020
Durata
55 Mesi
Enti finanziatori
Stato
Concluso
Categoria
European and International Programmes / COST - European Cooperation in Science and Technology / Cost Action